|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.440 EUR | -0.64% |
|
-30.45% | -36.88% |
| 07-16 | Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40 | MT |
| 07-16 | EVOTEC : Deutsche Bank reaffirms its Neutral rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 700M | - | ||||
| 39.58B | - | - | - | - | - |
| 34.69B | |||||
| 34.42B | |||||
| 27.11B | |||||
| 16.21B | - |
- Stock Market
- Stocks
- EVT Stock
- Charts Evotec SE
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
